Artelo Biosciences
ARTL
13 hedge funds and large institutions have $2.17M invested in Artelo Biosciences in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
785% more capital invested
Capital invested by funds: $245K → $2.17M (+$1.92M)
225% more funds holding
Funds holding: 4 → 13 (+9)
0.02% more ownership
Funds ownership: 0.01% → 0.03% (+0.02%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$393K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$369K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$286K |
| 4 |
VF
Virtu Financial
New York
|
+$244K |
| 5 |
Bank of New York Mellon
New York
|
+$162K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$79.1K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $404K | +$393K | +919 | New |
|
|
BFM
2
Boothbay Fund Management
New York
| $380K | +$369K | +863 | New |
|
|
KC
3
Kepos Capital
New York
| $326K | -$79.1K | -185 | -20% |
|
|
4
Citadel Advisors
Miami,
Florida
| $295K | +$286K | +670 | New |
|
|
VF
5
Virtu Financial
New York
| $251K | +$244K | +570 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $230K | +$127K | +298 | +132% |
|
|
7
Bank of New York Mellon
New York
| $167K | +$162K | +379 | New |
|
8
Jane Street
New York
| $34K | +$33.3K | +78 | New |
|
|
LCM
9
LVM Capital Management
Portage,
Michigan
| $33K | +$31.6K | +74 | New |
|
10
UBS Group
Zurich,
Switzerland
| $26K | +$24.8K | +58 | New |
|
11
Northern Trust
Chicago,
Illinois
| $20K | – | – | – |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $2K | +$2.14K | +5 | New |
|
|
CS
13
Credit Suisse
Zurich,
Switzerland
| – | -$9K | -44 | Closed |
|
14
Bank of America
Charlotte,
North Carolina
| – | +$428 | +1 | New |
|
ARTL Hedge Fund Activity: Q1 2021 in Review
13 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q1 2021, worth a combined $2.17M — up 785% from $245K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ARTL positions and 1 closed out — a net gain of 9 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $393K. The largest seller was Kepos Capital, cutting an estimated $79.1K.
- 13 institutional investors held Artelo Biosciences (ARTL) as of Q1 2021, up from 4 in Q4 2020.
- Funds reported $2.17M of Artelo Biosciences stock for Q1 2021, up 785% quarter-over-quarter.
- 10 funds opened new Artelo Biosciences positions in Q1 2021 and 1 closed out, a net change of +9 holders.
- The largest Artelo Biosciences buyer in Q1 2021 was Vanguard Group, an estimated $393K added.
- The largest Artelo Biosciences seller in Q1 2021 was Kepos Capital, an estimated $79.1K sold.
Based on aggregated 13F filings for Q1 2021.